{"url":"https://lda.senate.gov/api/v1/filings/d6cbb9e6-e312-4797-98c4-2bc2f671df03/","filing_uuid":"d6cbb9e6-e312-4797-98c4-2bc2f671df03","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2020,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d6cbb9e6-e312-4797-98c4-2bc2f671df03/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michaela Sims","dt_posted":"2020-10-20T15:49:53.800000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street NW, Suite 900 South","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104546,"url":"https://lda.senate.gov/api/v1/registrants/401104546/","house_registrant_id":null,"name":"SIMS STRATEGIES, LLC","description":"Public Policy Consulting Firm","address_1":"2001 L Street NW, Suite 500","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAELA SIMS","contact_telephone":"+1 202-503-8832","dt_updated":"2026-07-23T14:17:47.193810-04:00"},"client":{"id":202021,"url":"https://lda.senate.gov/api/v1/clients/202021/","client_id":48,"name":"AMAG PHARMACEUTICAL","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-07-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pharmaceutical issues related to womens health product access.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66699,"prefix":null,"prefix_display":null,"first_name":"MICHAELA","nickname":null,"middle_name":null,"last_name":"SIMS","suffix":null,"suffix_display":null},"covered_position":"Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)","new":false},{"lobbyist":{"id":66697,"prefix":null,"prefix_display":null,"first_name":"EDWARD","nickname":null,"middle_name":null,"last_name":"PRETTYMAN","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}